SQ28603 is a potent and selective inhibitor of neutral endopeptidase (NEP; EC 3.4.24.11), used to lower mean arterial pressure (MAP), increase plasma atrial natriuretic peptide (ANP) concentrations, enhance urinary excretion of cyclic guanosine monophosphate (cGMP), and promote natriuresis in hypertensive models such as deoxycorticosterone acetate (DOCA)/salt hypertensive rats and conscious cynomolgus monkeys.